Books > Science & Mathematics > Physics > Applied physics & special topics > Biophysics
|
Buy Now
Cancer Neutron Capture Therapy (Paperback, Softcover reprint of the original 1st ed. 1996)
Loot Price: R8,326
Discovery Miles 83 260
|
|
Cancer Neutron Capture Therapy (Paperback, Softcover reprint of the original 1st ed. 1996)
Expected to ship within 10 - 15 working days
|
Donate to Against Period Poverty
Total price: R8,346
Discovery Miles: 83 460
|
There are many human cancers which actively synthesize specific
characteristic proteins such as melanomas, thyroid cancer and
squamous cell carcinoma. Many cancer researchers have of course
tried to utilize this specific activity as a key for the selective
treatment of cancers. In the past for example, the molecular hybrid
compound of DOPA, a substrate of melanin, and nitrogen mustard
N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized
as Melphalan and used to treat malignant melanoma. A major problem
arose though in that it was soon found to be highly suppressive
toward bone marrow and quite toxic while not being remarkably
effective. Thus, malignant melanoma could not be cured by it. Such
failure led us to develop a novel bimodal therapeutic system which
includes the use of non-toxic potentially cytocidal chemicals which
selectively accumulate within the cancer cells and which are
converted by a controllable modality into an actively cytocidal
element in situ. We can now non-surgically cure malignant melanoma
and glioblastoma with our selective cancer treatment, neutron
capture therapy (NCT); as can be found in this volume. Included are
124 papers on the latest breaking developments discussed at the
Sixth International Symposium on NCT for Cancer held in Kobe during
the late autumn of 1994.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.